U.S. Drug Enforcement Administration

Cannabis Rescheduling Could Reverse 'Decades Of Misguided Drug Policy,' Says Key Industry Organization Following DEA Hearing Rescheduling (UPDATED)
DEA vs. Georgia: Tensions Rise Over Medical Cannabis Access As State Regulators Consider Legal Action
Veterans' Letter To President Biden Seeks Swift Marijuana Rescheduling And Federal Legalization
DEA vs. Georgia: Tensions Rise Over Medical Cannabis Access As State Regulators Consider Legal Action
Veterans' Letter To President Biden Seeks Swift Marijuana Rescheduling And Federal Legalization
DEA-Registered Marijuana Producer's Q3 2023 Financial Report: Reduced Expenses, Strategic Focus, Aligned Net Loss
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More

U.S. Drug Enforcement Administration Recent News

How Will HHS Recommendation To The DEA Impact Cannabis Brands? Find Out At This Leading Cannabis Finance Conference
Legislation Milestone: The Cannabis Rescheduling Debate Might Impact Brands The shifting perception of cannabis in the United States is witnessing a significant turning point.
Cannabis Landscape Update: Legalization Impact, Revenue Projections, Regulatory Challenges & Industry Initiatives
The U.S. cannabis landscape is in a dynamic state of change, with policy shifts and legislative updates shaping the industry's future. 
Federal Cannabis Scheduling Decision Expected 'This Year,' Says Biden's Health Secretary
The U.S.
Post-Pandemic Future Uncertain For Ketamine Telehealth Clinics Amid DEA Backlash
The future of ketamine telehealth clinics, the number of which grew during the Covid-19 pandemic, is uncertain due to new rules from the Drug Enforcement Administration (DEA).
DEA States Delta-8 And -9 THCO Are Controlled Substances Despite Hemp Bill
The U.S. Drug Enforcement Administration (DEA) announced Monday that delta-9-THCO and delta-8-THCO do not occur naturally in the cannabis plant and can only be obtained synthetically.
DEA Sued Over Delays To Open Records For Psychedelics And Cannabis
The Drug Enforcement Administration (DEA) has been sued over a failure to respond in due time to requests for psychedelics and cannabis records, reported Marijuana Moment.
Right To Try Laws: Psilocybin For End-Of-Life Care Poses Ongoing Battle With The DEA
A group of terminally ill patients seeking psilocybin therapy will likely take the Drug Enforcement Administration (DEA) to federal court once again over the agency’s denial to grant access to the treatment under Right To Try (RTT) laws, The Microdose
DEA Sets Public Hearing On Project Banning Psychedelics To Be Held In August
In a document published in the Federal Register, the Drug Enforcement Administration (DEA) announced it will hold a hearing on August 22, 2022, on its controversial propo
Congressional Report Says Mexican Cartel Profits Dropping Due Marijuana Legalization Advance
According to an updated Congressional report, demand for illicit marijuana from Mexico continues to drop since cannabis is legal in the U.S. and Canada. Apparently, the international drug trade is shifting as the legalization movement expands.
This Day In Market History: The 2000 Presidential Election

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved